Videocapsule endoscopy
Conditions
Interventions
Colon capsule endoscopy with corresponding bowel preparation
Sponsors
Erasmus Medical Center
Eligibility
Inclusion criteria
Inclusion criteria: Subject aged 50 untill 74 years old; Participation in the Rotterdam study
Exclusion criteria
Exclusion criteria: Inability or refusal to provide informed consent; Persons with a severe or terminal disease with a life-expectancy of less than 5 years; Dysphagia or other swallowing disorder which makes it impossible to swallow the capsule; Renal failure, eGFR <30 ml/min/1.73m2; Subject has congestive heart failure (NYHA class 3 and 4); Subject has any allergy or other known contraindication to the medications used in the study; High risk of capsule retention: IBD, Personal history of Gastrointestinal surgery other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator; Cardiac pacemakers or other implanted electro-medical equipment; Subject is expected to undergo MRI examination within14 days after ingestion of the capsule; Presumably or proven congenital long QT syndrome; Participants who use medication that give an extension of the QT- interval; subject has insulin dependent diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of gastrointestinal disorders, visualized with colon capsule endoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| Participation, prevalence of adverse events; burden of colon capsule endoscopy (CCE); compare results CCE with result endoscopy; referral rate; compare patient characteristics, medication use and demographical aspects between persons with and without found lesions. | — |
Contacts
Public ContactM.C.W. Spaander
Erasmus Medical Center Rotterdam
Outcome results
None listed